Related Experiment Videos

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), its metabolite cyperquat (MPP+) and energy transduction in

J H Thakar1, M N Hassan, J D Grimes

  • 1Parkinson's Disease Laboratory, Ottawa Civic Hospital, Ontario, Canada.

Insights

The neurotoxin MPP+, not MPTP, impairs mitochondrial energy production in rat brain and liver cells. Calcium uptake by mitochondria was unaffected by MPP+ in this in vitro study.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Toxicology

Background:

  • Mitochondrial dysfunction is implicated in neurodegenerative diseases.
  • MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a neurotoxin that causes Parkinsonism.
  • MPTP is metabolized to MPP+ (1-methyl-4-phenylpyridinium), the active toxic species.

Purpose of the Study:

  • To investigate the effects of MPTP and MPP+ on mitochondrial energy transduction.
  • To examine the impact of these compounds on calcium uptake in isolated mitochondria.

Main Methods:

  • In vitro studies using isolated mitochondria from rat striatum and liver.
  • Measurement of oxygen consumption rates (state 3) with pyruvate-malate (NAD-linked) and succinate (FAD-linked) substrates.
  • Assessment of 45Ca uptake in the presence and absence of Mg.ADP.

Main Results:

  • MPTP showed minimal effects on mitochondrial energy transduction.
  • MPP+ significantly inhibited NAD-linked substrate oxidation (pyruvate-malate) in both striatal and liver mitochondria.
  • MPP+ did not affect oxidative phosphorylation with succinate.
  • MPP+ had negligible effects on 45Ca uptake by mitochondria, even with Mg.ADP.

Conclusions:

  • MPP+ directly impairs mitochondrial energy metabolism via inhibition of NAD-linked substrate oxidation.
  • The neurotoxic effects of MPTP likely involve the inhibition of mitochondrial respiration by its metabolite, MPP+.
  • MPP+ does not appear to significantly disrupt mitochondrial calcium handling in vitro.

Related Concept Videos